Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review

[1]  Li Ding,et al.  Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. , 2014, Cell reports.

[2]  A. Satelli,et al.  Universal marker and detection tool for human sarcoma circulating tumor cells. , 2014, Cancer research.

[3]  L. Trani,et al.  Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  A. Davidoff,et al.  Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience. , 2012, Journal of pediatric surgery.

[5]  M. van Glabbeke,et al.  Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. , 2011, European journal of cancer.

[6]  N. Daw,et al.  Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience , 2008, Cancer.

[7]  B. Crompton,et al.  Survival after recurrence of osteosarcoma: A 20‐year experience at a single institution , 2006, Pediatric blood & cancer.

[8]  Piero Picci,et al.  Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. , 2005, European journal of cancer.

[9]  S. Ferrari,et al.  Resection of recurrent pulmonary metastases in patients with osteosarcoma , 2005, Cancer.

[10]  S. Ferrari,et al.  Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. , 2005, European journal of cancer.

[11]  E. Kleinerman,et al.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Semik,et al.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Ferrari,et al.  Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy , 2005, Acta oncologica.

[14]  A. Huvos,et al.  The patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience , 2004, Pediatric blood & cancer.

[15]  D. Hawkins,et al.  Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy , 2003, Cancer.

[16]  S. Ferrari,et al.  Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Huvos,et al.  Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Pappo,et al.  Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience. , 1996, Medical and pediatric oncology.

[19]  O. S. Nielsen,et al.  Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients , 1996, Cancer.

[20]  R. Grimer,et al.  Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. , 1991, Thorax.

[21]  N. Jaffe,et al.  Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. , 2006, Journal of pediatric surgery.

[22]  A. Pappo,et al.  Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Huvos.  Bone tumors, diagnosis, treatment, and prognosis , 1979 .